P-tau species, in particular p-tau181, have been identified as a promising avenue for detecting AD co-pathology and have been shown to possess prognostic value in alpha-synucleinopathies, as recently evidenced in DLB [17, 18]. Here, MAPT is linked to Lewy body dementia.